Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05254210 · ClinicalTrials.gov registry record · NA
Feasibility Study To Collect Safety And Preliminary Efficacy Data For A Radiofrequency Microneedling Device
A NA study, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT05254210 is a NA study that has completed, run by Cynosure. The registered enrollment target is 10 participants.
The verdict
NCT05254210, a NA study, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The intended use of the Potenza™ device is to collect clinical data for brow lifting and/or treatment of dermatologic conditions in which electrocoagulation and hemostasis is a viable mechanism for means of improvement.
Interventions
- DEVICE RF Device (Potenza™)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-09-13 |
| Est. Completion | 2022-05-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05254210
The ClinicalTrials.gov registry entry for NCT05254210 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cynosure, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RF Device (Potenza™) is the first listed.
NCT05254210 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05254210 about?
NCT05254210 is a clinical study titled "Feasibility Study To Collect Safety And Preliminary Efficacy Data For A Radiofrequency Microneedling Device". The intended use of the Potenza™ device is to collect clinical data for brow lifting and/or treatment of dermatologic conditions in which electrocoagulation and hemostasis is a viable mechanism for means of improvement.
What is the current status of trial NCT05254210?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-09-13. Estimated completion is 2022-05-17.
What interventions are being tested in trial NCT05254210?
The interventions under investigation include: RF Device (Potenza™) (DEVICE).
Who is sponsoring clinical trial NCT05254210?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.